Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $70,059 | 34 | 50.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,000 | 12 | 16.6% |
| Honoraria | $20,000 | 6 | 14.5% |
| Unspecified | $9,759 | 2 | 7.1% |
| Food and Beverage | $8,096 | 152 | 5.9% |
| Travel and Lodging | $7,211 | 43 | 5.2% |
| Education | $172.03 | 5 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $33,723 | 32 | $0 (2022) |
| Lundbeck LLC | $30,537 | 30 | $0 (2021) |
| Allergan, Inc. | $22,484 | 48 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $20,875 | 27 | $0 (2020) |
| Lilly USA, LLC | $17,363 | 53 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $7,532 | 10 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,000 | 1 | $0 (2022) |
| Eli Lilly and Company | $1,137 | 2 | $0 (2018) |
| EMD Serono, Inc. | $999.24 | 25 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $521.90 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $347.51 | 7 | Lilly USA, LLC ($244.87) |
| 2023 | $342.42 | 8 | EMD Serono, Inc. ($138.43) |
| 2022 | $2,301 | 7 | Biohaven Pharmaceutical Holding Company Ltd. ($2,000) |
| 2021 | $38,025 | 27 | Amgen Inc. ($17,114) |
| 2020 | $39,155 | 57 | Lundbeck LLC ($14,449) |
| 2019 | $19,985 | 77 | Lilly USA, LLC ($7,652) |
| 2018 | $14,630 | 38 | Teva Pharmaceuticals USA, Inc. ($7,155) |
| 2017 | $23,512 | 33 | Lilly USA, LLC ($8,275) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Neuroscience | ||||||
| 09/03/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $44.37 | General |
| Category: Neuroscience | ||||||
| 07/03/2024 | Biogen, Inc. | QALSODY (Drug), SKYCLARYS, TYSABRI | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Neurology | ||||||
| 06/25/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $88.80 | General |
| Category: Neuroscience | ||||||
| 05/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.13 | General |
| 02/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $44.28 | General |
| 01/11/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $84.56 | General |
| Category: Neuroscience | ||||||
| 10/05/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $33.41 | General |
| Category: Neurology | ||||||
| 09/15/2023 | Biogen, Inc. | QALSODY (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Neurology | ||||||
| 08/04/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $28.44 | General |
| Category: Neurology | ||||||
| 06/23/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $37.62 | General |
| Category: Neurology | ||||||
| 06/23/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 03/04/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $33.22 | General |
| 01/19/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $38.96 | General |
| Category: Neurology | ||||||
| 01/04/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $120.88 | General |
| Category: Neurology | ||||||
| 10/13/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $48.35 | General |
| 09/21/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Migraine | ||||||
| 07/13/2022 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $123.74 | General |
| Category: Neurology | ||||||
| 06/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: PRIMARY CARE | ||||||
| 04/02/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $52.94 | General |
| 02/10/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Neuroscience | ||||||
| 01/19/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.79 | General |
| 11/20/2021 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROLOGY | ||||||
| 11/17/2021 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $7,573.50 | General |
| Category: Neuroscience | ||||||
| 10/12/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $117.12 | General |
| Category: PRIMARY CARE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A narrative review of the importance of pharmacokinetics and drugdrug interactions of preventive therapies in migraine management | Amgen Inc. | $9,530 | 1 |
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $229.20 | 1 |
About Sylvia Lucas
Sylvia Lucas is a Neurology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215012026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sylvia Lucas has received a total of $138,297 in payments from pharmaceutical and medical device companies, with $347.51 received in 2024. These payments were reported across 254 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($70,059).
Practice Information
- Specialty Neurology
- Location Seattle, WA
- Active Since 10/27/2006
- Last Updated 02/20/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1215012026
Products in Payments
- Aimovig (Biological) $26,571
- VYEPTI (Biological) $18,235
- UBRELVY (Drug) $16,092
- NURTEC ODT (Drug) $9,532
- TEV-48125 (Biological) $7,315
- AJOVY (Biological) $5,950
- BOTOX - MIGRAINE (Drug) $5,424
- AJOVY (Drug) $539.14
- BOTOX (Biological) $453.77
- EMGALITY (Drug) $392.64
- ONZETRA Xsail (Drug) $295.56
- AIMOVIG (Biological) $229.20
- BOTOX - NEUROLOGY (Drug) $209.85
- Mavenclad (Biological) $177.02
- BOTOX (Drug) $162.63
- TYSABRI (Biological) $150.00
- Mavenclad (Drug) $148.55
- Trudhesa (Drug) $145.55
- BOTOX CHRONIC MIGRAINE (Drug) $141.54
- MAVENCLAD (Drug) $138.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Seattle
Dr. Pavle Repovic, Md, Phd, MD, PHD
Neurology — Payments: $1.2M
Nathaniel Watson, Md, MD
Neurology — Payments: $352,101
Mariko Kita, Md, MD
Neurology — Payments: $243,050
Kyra Becker
Neurology — Payments: $239,174
Christyn Edmundson, Md, MD
Neurology — Payments: $226,530
Pravin Khemani, Md, MD
Neurology — Payments: $199,884